ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4 | -60.0% | 188 | -24.8% | 0.00% | – |
Q1 2023 | $10 | -9.1% | 250 | 0.0% | 0.00% | – |
Q4 2022 | $11 | -100.0% | 250 | -89.7% | 0.00% | – |
Q4 2021 | $181,000 | +5933.3% | 2,428 | +3368.6% | 0.00% | – |
Q2 2020 | $3,000 | -86.4% | 70 | -84.1% | 0.00% | – |
Q1 2020 | $22,000 | -58.5% | 441 | -50.6% | 0.00% | – |
Q3 2019 | $53,000 | +140.9% | 893 | +182.6% | 0.00% | – |
Q4 2018 | $22,000 | -95.7% | 316 | -92.8% | 0.00% | -100.0% |
Q2 2018 | $508,000 | +53.5% | 4,390 | -22.2% | 0.00% | -85.7% |
Q4 2017 | $331,000 | +86.0% | 5,644 | +14.0% | 0.01% | +75.0% |
Q2 2017 | $178,000 | +3460.0% | 4,953 | +2779.7% | 0.01% | – |
Q1 2016 | $5,000 | -98.4% | 172 | -98.2% | 0.00% | -100.0% |
Q4 2015 | $312,000 | +1542.1% | 9,472 | +1622.2% | 0.02% | +2300.0% |
Q3 2015 | $19,000 | -26.9% | 550 | -4.8% | 0.00% | -50.0% |
Q2 2015 | $26,000 | -7.1% | 578 | -38.7% | 0.00% | -33.3% |
Q1 2015 | $28,000 | -67.1% | 943 | -43.8% | 0.00% | -70.0% |
Q4 2014 | $85,000 | – | 1,679 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |